ACADIAN ASSET MANAGEMENT LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 916542 Boston, MA

Position in BCYC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,344,426

-$787,210 QoQ

Shares Held

1,968,025

0.0% QoQ

Ownership

2.81%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 103 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. BCYC ranks #21 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,344,426	1,968,025	0.0%	Shares	Defined	2026-08-13
2026-03-31	$9,131,636	1,968,025	+17.8%	Shares	Defined	2026-05-13
2025-12-31	$11,832,506	1,671,258	+27.1%	Shares	Defined	2026-02-10
2025-09-30	$10,174,663	1,314,556	+88.2%	Shares	Defined	2025-11-13
2025-06-30	$4,854,581	698,501	+454.1%	Shares	Defined	2025-08-07
2025-03-31	$1,070,266	126,062	+121.5%	Shares	Defined	2025-05-21
2022-06-30	$954,933	56,909	+58.3%	Shares	Defined	2022-08-09
2022-03-31	$1,577,880	35,959	-79.9%	Shares	Defined	2022-05-12
2021-12-31	$10,867,668	178,539	+743.2%	Shares	Defined	2022-02-10
2021-09-30	$880,626	21,174	+136.5%	Shares	Defined	2021-11-12
2021-06-30	$271,813	8,953	-76.7%	Shares	Defined	2021-08-11
2021-03-31	$1,148,800	38,460	+236.5%	Shares	Defined	2021-05-11
2020-12-31	$205,186	11,431	—	Shares	Defined	2021-02-11
No filing history on record for this holder in this stock.